Poly Medicure Limited — Statement of deviation(s) or variation(s) under Reg. 32

Poly Medicure Limited has submitted a formal statement to the stock exchange regarding a deviation or variation. This regulatory filing is required when a company's actual financial performance or business activities differ from what was previously disclosed in a public announcement or prospectus. The company has now provided the necessary details to the exchange to ensure full transparency with the market.

For investors, this disclosure is a standard compliance measure rather than a major operational event. It signals that the company is adhering to disclosure norms by keeping the market updated on any changes to its original plans or financial outlook. This helps maintain trust and ensures that investors have access to accurate and timely information.

Investors should look for the specific details within the exchange filing to understand the nature of the deviation. It is advisable to monitor the company's future quarterly reports to see if these variations have a material impact on its financial health or business trajectory.